News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
1. “7 Habits of Highly Successful Entrepreneurs” – This article from Entrepreneur provides an overview of the key habits of successful entrepreneurs, such as setting goals, staying organized and networking. 2. “How to Start an Online Business” – This step-by-step guide from Entrepreneur outlines the process of starting an online business from the ground up, from market research to choosing a platform to building a website. 3. “The Future of Entrepreneurship” – This video from the World Economic Forum looks at the changing landscape of entrepreneurship and how technology is playing a role in its growth. 4. “10 Tips for Scaling Your Business” – This article from Entrepreneur provides practical advice on how to scale a business, from refining processes to gaining market share. 5. “5 Steps to Launching a Start-up” – This video from the Financial Times explains the steps to launching a start-up, from creating a business plan to securing funding.
Affiliate marketing is a type of performance-based marketing in which a business rewards one or more affiliates for each visitor or customer brought by the affiliate’s own marketing efforts. For you to perform well as an affiliate marketer, you need to understand the basics of marketing. This involves knowing how to make people buy your […]
Expanding your business abroad is one of the super-easy ways to build a multinational company. It might not be easy at first, but it is highly obtainable. To go global with your American business idea, there are factors you need to consider. In this article, we shall look at everything you need to know about […]
Making legitimate money is not hard if you can put your life out there and encourage someone with your weight loss journey. You hear people say things like, “Cash is king, and Money is the motivation.” This means that when there is a possibility to earn from something, it doubles your energy for that thing. […]
What would you consider to be one of the latest small business recruiting trends of 2025? What are the statistics of small businesses in Singapore, the UK, the United States, Australia and Canada using free HR software? Businesses have faced unprecedented challenges in the past 18 months as they have tried to adapt to the […]
Data breaches in the United States are on the increase and the only way to protect your online accounts is by using stronger and more secure passwords. As of July 2021, about 3,980,757,735 breached records have been noticed in the United Kingdom. According to the Risk-Based Security’s 2021 Mid Year Data Breach QuickView Report, it […]
STOCKHOLM, SWEDEN – April 1, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition presents recent preclinical data showing that golexanolone reverses dopamine loss and sustains improvements of Parkinsonian symptoms at the 19th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) 2025, in Vienna, Austria, April 1–5th. Parkinson’s disease is a progressive neurodegenerative disease hallmarked by motor symptoms and disrupted cognitive functions as well as mental health. The disorder is caused by the loss of nerve cells in the brain that produce the signaling substance dopamine, which leads to various symptoms reducing the patient’s well-being and quality of life. Umecrine Cognition is developing a new class of drugs to alleviate cognitive symptoms. The company's drug candidate golexanolone has recently shown to improve mechanisms in the midbrain important for brain functions such as motor and cognitive behaviors that leads to dopamine loss and Parkinsonian deficits in a preclinical study in a well-established laboratory model of Parkinson’s disease. The results from the study increase the understanding of golexanolone’s mechanism of action and support further development of the drug candidate as a potential treatment for Parkinson’s disease. An abstract summarizing the company’s study has been accepted for presentation at the on-site paper poster session “Alpha-Synucleinopathies, Therapeutic Targets, Mechanisms for Treatment” on Friday, April 4th, as well as at the oral ePoster presentation, a virtual format for digital meeting attendees. Karolinska Development's ownership in Umecrine Cognition amounts to 73%. For further information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Johan Dighed, General Counsel and Deputy CEO, Karolinska Development ABPhone: +46 70 207 48 26, e-mail: johan.dighed@karolinskadevelopment.com TO THE EDITORS About Karolinska Development ABKarolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The company focuses on identifying breakthrough medical innovations in the Nordic region that are developed by entrepreneurs and leadership teams. The company invests in the creation and growth of companies that advance these assets into commercial products that are designed to make a difference to patient’s lives while providing an attractive return on investment to shareholders. Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success. Karolinska Development has a portfolio of eleven companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases. The company is led by an entrepreneurial team of investment professionals with a proven track record as company builders and with access to a strong global network. For more information, please visit www.karolinskadevelopment.com. Attachment KD Umecrine Cognition ADPD dopamine loss_eng
Forbes reports that 3,028 entrepreneurs are listed on the World's Billionaires List for the year, which is 247 more than the previous year. Additionally, their combined wealth has increased by $2 trillion, for a total value of $16.1 trillion. Get more World News and Business News on Zee Business.